ATE407129T1 - Pentafluoroalkylsulfin-naphthaline und und darauf bezogene modulatoren des östrogenrezeptors - Google Patents

Pentafluoroalkylsulfin-naphthaline und und darauf bezogene modulatoren des östrogenrezeptors

Info

Publication number
ATE407129T1
ATE407129T1 AT04751764T AT04751764T ATE407129T1 AT E407129 T1 ATE407129 T1 AT E407129T1 AT 04751764 T AT04751764 T AT 04751764T AT 04751764 T AT04751764 T AT 04751764T AT E407129 T1 ATE407129 T1 AT E407129T1
Authority
AT
Austria
Prior art keywords
pentafluoroalkylsulfin
naphthalines
estrogen receptor
alkyl
related modulators
Prior art date
Application number
AT04751764T
Other languages
English (en)
Inventor
Jeffrey Dodge
Norman Hughes
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE407129T1 publication Critical patent/ATE407129T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/12—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Lubricants (AREA)
AT04751764T 2003-06-10 2004-05-27 Pentafluoroalkylsulfin-naphthaline und und darauf bezogene modulatoren des östrogenrezeptors ATE407129T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47727203P 2003-06-10 2003-06-10

Publications (1)

Publication Number Publication Date
ATE407129T1 true ATE407129T1 (de) 2008-09-15

Family

ID=33551698

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04751764T ATE407129T1 (de) 2003-06-10 2004-05-27 Pentafluoroalkylsulfin-naphthaline und und darauf bezogene modulatoren des östrogenrezeptors

Country Status (6)

Country Link
US (1) US7462647B2 (de)
EP (1) EP1641774B1 (de)
AT (1) ATE407129T1 (de)
DE (1) DE602004016331D1 (de)
ES (1) ES2311837T3 (de)
WO (1) WO2005000834A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE039052T2 (hu) 2013-02-19 2018-12-28 Novartis Ag Benzotiofénszármazékok és azok készítményei szelektív ösztrogén receptor lebontóként

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5567828A (en) * 1995-06-07 1996-10-22 Eli Lilly And Company Compounds and compositions with nitrogen-containing non-basic side
DE19526146A1 (de) * 1995-07-07 1997-01-09 Schering Ag Triphenylethylene, Verfahren zu deren Herstellung, diese Triphenylethylene enthaltene pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
US6090843A (en) * 1997-08-11 2000-07-18 Eli Lilly And Company Benzothiophenes compounds which have useful pharmaceutical activity
AU9493698A (en) * 1997-09-23 1999-04-12 Eli Lilly And Company Benzothiophenes
WO2001027127A1 (en) * 1999-10-08 2001-04-19 Strakan Group Plc Tamoxifen and tamoxifen analogue glycosides and uses thereof
US6737417B2 (en) * 1999-12-13 2004-05-18 Chugai Seiyaku Kabushiki Kaisha Compounds with hydroxycarbonyl-halogenoalkyl side chain

Also Published As

Publication number Publication date
EP1641774A1 (de) 2006-04-05
EP1641774B1 (de) 2008-09-03
US20070054956A1 (en) 2007-03-08
US7462647B2 (en) 2008-12-09
DE602004016331D1 (de) 2008-10-16
WO2005000834A1 (en) 2005-01-06
ES2311837T3 (es) 2009-02-16

Similar Documents

Publication Publication Date Title
NO20074641L (no) 1-Acetic Acid-Indole Derivatives with PGD2 Antagonist Activity
AR041009A1 (es) Compuestos heterociclicos nitrogenados que presentan actividad inhibitoria contra la integrasa del vih
BR0306292A (pt) Composto de éster e uso medicinal do mesmo
DK1104760T3 (da) Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler
BR0206955A (pt) Ligantes de receptores de canabinóides
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
MXPA06001274A (es) Compuestos novedosos que poseen actividad inhibitoria contra transporador dependiente de sodio.
CO5550421A2 (es) Derivados de indol utiles para el tratamiento de enfermeda- des
TR200302047T4 (tr) Anti-iltihabik / analjezik maddeler olarak heteroaril fenil pirazol bileşikleri.
ATE322264T1 (de) Medizinische zusammensetzungen als begleittherapie gegen krebs
TNSN07349A1 (fr) Derives de n-(n-sulfonylaminomethyl) cyclopropanecarboxamide utiles pour le traitement de la douleur
TW200800938A (en) Indole carboxylic acid derivatives exhibiting PGD2 receptor antagonism
BRPI0418074B8 (pt) derivado de amida, composição farmacêutica, inibidor da tirosina cinase bcr-abl e agentes terapêuticos
YU24503A (sh) Novi tiadiazoli i oksadiazoli i njihova upotreba kao inhibitora fosfodiesteraze-7
DE602004026071D1 (de) Aminopyrone und ihre verwendung als atm inhibitoren
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
BR0308145A (pt) Composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
BRPI0518068A (pt) composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada
TW200612920A (en) Novel imidazolidine derivatives
HRP20090474T1 (hr) Postupak i intermedijeri za sintezu kaspofungina
DE60330758D1 (de) Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen
HUP0100184A2 (hu) Szubsztituált 2-(benzil-amino)-2-fenil-acetamid-vegyületek és ezeket tartalmazó gyógyszerkészítmények
MA29559B1 (fr) Derives de 4,5-diarylpyrrole, leur preparation et leur application en therapeutique
DE602004016331D1 (de) Pentafluoroalkylsulfin-naphthaline und und darauf bezogene modulatoren des östrogenrezeptors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties